Assessment of Past Glycemic Control: Measure Fructosamine, Hemoglobin A1, or Both?

M. Dominiczak,Lorna A Smith,Joyce McNaught,K. Paterson
DOI: https://doi.org/10.2337/diacare.11.4.359
1988-04-01
Diabetes Care
Abstract:M easurement of serum fructosamine is a simple, fast, and inexpensive method for the quantitation of glycosylated serum proteins (1,2). Fructosamine level correlated with hemoglobin A, (HbA,) in diabetic patients in several studies (1,3,4). However, whereas fructosamine and glycosylated serum protein levels reflect the integrated glycemia over ~2 wk (1,5), HbA, reflects integrated glycemia over 4-6 wk (5). Because it has been suggested that fructosamine can be used as a substitute for HbA, assay in the monitoring of diabetic patients, we investigated the relationship between the two in a group of 77 randomly selected diabetic patients [with insulin-dependent (IDDM) or noninsulin-dependent (NIDDM) diabetes mellitus] tested without prior warning at a diabetic outpatient clinic. Sixteen nondiabetic control subjects were also tested. Serum fructosamine was measured by the nitro blue tetrazolium reduction method at pH 10.35 with a reagent kit (kindly provided by Roche Diagnostics, Welwyn Garden City, UK) with secondary protein-based standards originally standardized against 1-deoxy-1morpholino-D-fructose (DMF) (6). The assay was performed on an RA-1000 random access analyzer (Technicon, Tarrytown, NY). HbA, was measured by affinity chromatography with a GlycoGel B minicolumn system (Glycotest, Pierce, UK; 7). Fructosamine level was 2.11 ± 0.06 mM (mean ± SD) in nondiabetic subjects and 3.44 ± 0.65 mM in Fructosamine (mmol/1)
What problem does this paper attempt to address?